MRI around the time of diagnostic biopsy may identify patients at increased risk for early reclassification during prostate cancer active surveillance.

A new study finds that harms of overdiagnosing prostate cancer is lessened when MRI is used as well as PSA tests.

Omitting systematic biopsy in men with elevated prostate-specific antigen (PSA) levels and negative MRI results, and ...

Omitting biopsy in patients with negative magnetic resonance imaging (MRI) results is associated with a significantly reduced ...

Researchers at Case Western Reserve University and Vanderbilt University are pioneering a new approach to prostate cancer ...

Data on the efficacy and safety of screening for prostate cancer with magnetic resonance imaging (MRI) are needed from studies of follow-up screening. In a population-based trial that started in ...

Getting screened for cancer is a stressful experience, especially when the methods can be invasive. New research indicates ...

Detection of clinically insignificant ISUP grade group 1 prostate cancer decreases by 57% under a prostate cancer screening strategy of MRI-targeted biopsy only rather than systematic biopsy in men ...

As Prostate Cancer Awareness Month comes to an end, a local doctor is reminding all men that prostate cancer awareness is ...

The risk of prostate cancer rises very steeply with age and as per the CDC, 66% of cases are reported in males above 65 yr of ...

HOUSTON — September is Prostate Cancer Awareness Month. One in eight men will be diagnosed during their lifetime, and it's ...